Compare TTK HEALTHCARE with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs LUPIN - Comparison Results

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE LUPIN TTK HEALTHCARE/
LUPIN
 
P/E (TTM) x 18.8 48.4 38.7% View Chart
P/BV x 1.5 2.5 60.5% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 TTK HEALTHCARE   LUPIN
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
LUPIN
Mar-19
TTK HEALTHCARE/
LUPIN
5-Yr Chart
Click to enlarge
High Rs1,215986 123.2%   
Low Rs610720 84.7%   
Sales per share (Unadj.) Rs444.4369.5 120.3%  
Earnings per share (Unadj.) Rs17.213.4 128.7%  
Cash flow per share (Unadj.) Rs27.637.4 73.9%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs177.9303.7 58.6%  
Shares outstanding (eoy) m14.13452.49 3.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.12.3 88.9%   
Avg P/E ratio x52.963.6 83.1%  
P/CF ratio (eoy) x33.022.8 144.7%  
Price / Book Value ratio x5.12.8 182.5%  
Dividend payout %29.00-   
Avg Mkt Cap Rs m12,894386,064 3.3%   
No. of employees `0002.317.7 13.1%   
Total wages/salary Rs m1,30731,513 4.1%   
Avg. sales/employee Rs Th2,715.79,453.8 28.7%   
Avg. wages/employee Rs Th565.31,782.0 31.7%   
Avg. net profit/employee Rs Th105.4343.0 30.7%   
INCOME DATA
Net Sales Rs m6,279167,182 3.8%  
Other income Rs m783,640 2.1%   
Total revenues Rs m6,356170,822 3.7%   
Gross profit Rs m49628,822 1.7%  
Depreciation Rs m14710,850 1.4%   
Interest Rs m343,078 1.1%   
Profit before tax Rs m39318,534 2.1%   
Minority Interest Rs m0-89 0.0%   
Prior Period Items Rs m038 0.0%   
Extraordinary Inc (Exp) Rs m0-3,400 0.0%   
Tax Rs m1499,017 1.7%   
Profit after tax Rs m2446,066 4.0%  
Gross profit margin %7.917.2 45.8%  
Effective tax rate %37.948.7 78.0%   
Net profit margin %3.93.6 107.0%  
BALANCE SHEET DATA
Current assets Rs m2,717138,536 2.0%   
Current liabilities Rs m1,57161,299 2.6%   
Net working cap to sales %18.346.2 39.5%  
Current ratio x1.72.3 76.5%  
Inventory Days Days3284 38.4%  
Debtors Days Days47112 41.5%  
Net fixed assets Rs m991127,516 0.8%   
Share capital Rs m141905 15.6%   
"Free" reserves Rs m2,373136,517 1.7%   
Net worth Rs m2,514137,422 1.8%   
Long term debt Rs m366,417 0.0%   
Total assets Rs m4,158279,494 1.5%  
Interest coverage x12.67.0 179.7%   
Debt to equity ratio x00.5 0.3%  
Sales to assets ratio x1.50.6 252.4%   
Return on assets %6.73.3 204.0%  
Return on equity %9.74.4 219.6%  
Return on capital %16.98.9 190.1%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22559,414 0.4%   
Fx outflow Rs m7122,282 0.3%   
Net fx Rs m15437,132 0.4%   
CASH FLOW
From Operations Rs m17316,660 1.0%  
From Investments Rs m97-32,825 -0.3%  
From Financial Activity Rs m-3077,441 -4.1%  
Net Cashflow Rs m-38-8,724 0.4%  

Share Holding

Indian Promoters % 65.4 46.6 140.3%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 3.7 11.3 32.7%  
FIIs % 5.2 31.9 16.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.1 255.4%  
Shareholders   12,723 98,259 12.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  WYETH LTD  GSK PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 20, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - ALEMBIC PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS